MAppFin BFinAdmin - Actinogen Medical Chief Officer
| ACW Stock | 0.02 0 4.00% |
Executive
MAppFin BFinAdmin is Chief Officer of Actinogen Medical
| Age | 66 |
| Address | 109 Pitt Street, Sydney, NSW, Australia, 2000 |
| Phone | 61 2 8964 7401 |
| Web | https://actinogen.com.au |
Actinogen Medical Management Efficiency
The company has return on total asset (ROA) of (0.4537) % which means that it has lost $0.4537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7881) %, meaning that it generated substantial loss on money invested by shareholders. Actinogen Medical's management efficiency ratios could be used to measure how well Actinogen Medical manages its routine affairs as well as how well it operates its assets and liabilities. Total Current Liabilities is likely to gain to about 1.4 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 11.2 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Siobhan Lane | Light Wonder | 42 | |
| Ashley Grech | Xero | N/A | |
| Felicia Mayo | Block Inc | N/A | |
| Steven BE | Xero | 66 | |
| Sean Lambright | Pro Medicus | N/A | |
| Nick Zangari | Light Wonder | N/A | |
| Alyssa Henry | Block Inc | 54 | |
| H Doran | Tamawood | N/A | |
| Nicole Reid | Xero | N/A | |
| Sukhinder Cassidy | Xero | 54 | |
| Jason Lee | Block Inc | N/A | |
| Richard Schneider | Light Wonder | 66 | |
| Dean Phizacklea | Cochlear | N/A | |
| Damien Tampling | Xero | N/A | |
| Mark Rees | Xero | N/A | |
| Chrysty Esperanza | Block Inc | N/A | |
| Toby CFA | Xero | N/A | |
| Robert Parente | Light Wonder | 63 | |
| Angad Soin | Xero | N/A | |
| Brad Levin | Pro Medicus | N/A | |
| AMCT BA | Macquarie Group | 59 | |
Management Performance
| Return On Equity | -0.79 | ||||
| Return On Asset | -0.45 |
Actinogen Medical Leadership Team
Elected by the shareholders, the Actinogen Medical's board of directors comprises two types of representatives: Actinogen Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Actinogen. The board's role is to monitor Actinogen Medical's management team and ensure that shareholders' interests are well served. Actinogen Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Actinogen Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBBS FRACP, CEO MD | ||
| DCPSA FFPM, Chief Officer | ||
| BCom IPAA, Chief Officer | ||
| MAppFin BFinAdmin, Chief Officer | ||
| BBus FCIS, Company Sec | ||
| Michael Roberts, Head Communications | ||
| Christian Toouli, Head Devel | ||
| Fujun Li, Head Manufacturing | ||
| Therese Russell, Head Infrastructure | ||
| Tamara Miller, VP Devel | ||
| Dana MD, Chief Board |
Actinogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Actinogen Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.79 | ||||
| Return On Asset | -0.45 | ||||
| Profit Margin | (1.31) % | ||||
| Operating Margin | (0.18) % | ||||
| Current Valuation | 69.19 M | ||||
| Shares Outstanding | 3.13 B | ||||
| Shares Owned By Insiders | 15.35 % | ||||
| Shares Owned By Institutions | 7.28 % | ||||
| Price To Book | 3.98 X | ||||
| Price To Sales | 7.57 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Actinogen Stock Analysis
When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.